SINOVA-M-14022 Luteinizing Hormone (LH) Quantitative Test Kit

Clinical Significance:
Increased Levels: Polycystic ovary syndrome (PCOS) (characterized by chronic anovulation and hyperandrogenism), Turner syndrome, primary gonadal insufficiency, premature ovarian failure, post-oophorectomy, menopause, or women in postmenopausal syndrome.
Decreased Levels: Hypothalamic-pituitary gonadal insufficiency, such as hypothalamic amenorrhea; prolonged use of contraceptive pills; post hormone replacement therapy, both LH and FSH levels may decrease.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing and monitoring conditions with elevated or decreased LH and FSH levels, such as PCOS, Turner syndrome, gonadal insufficiency, menopause, and hypothalamic amenorrhea.
Endocrinology and Gynecology Departments: To assess hormonal imbalances and monitor hormone replacement therapy.
Diagnostic Laboratories: For routine testing of LH and FSH levels in various clinical conditions.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc.
Global Health Programs: International health initiatives focusing on reproductive health and hormonal disorders in low-resource settings.